Successful Treatment of Refractory Guillain-Barré Syndrome with Alemtuzumab in a Patient with Chronic Lymphocytic Leukemia

Publisher： Karger

E-ISSN： 1421-9662|132|2|240-243

ISSN： 0001-5792

Source： Acta Haematologica, Vol.132, Iss.2, 2014-05, pp. : 240-243

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

USE OF HEALTHCARE, PATIENT SATISFACTION AND BURDEN OF CARE IN GUILLAIN-BARRÉ SYNDROME

By Forsberg Anette   de Pedro-Cuesta Jesús   Widén Holmqvist Lotta  

Journal of Rehabilitation Medicine, Vol. 38, Iss. 4, 2006-07 ,pp. : 230-236

Medical Journals Limited

Access to resources Recommend Favorite

Respiratory dysfunction in guillain-barré syndrome

By Orlikowski David   Prigent Hélène   Sharshar Tarek   Lofaso Frédéric   Raphael Jean  

Neurocritical Care, Vol. 1, Iss. 4, 2004-12 ,pp. : 415-422

Humana Press, Inc

Access to resources Recommend Favorite

Clinical activity of a new regimen combining gemcitabine and alemtuzumab in high‐risk relapsed/refractory chronic lymphocytic leukemia patients

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 1, 2015-01 ,pp. : 37-42

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant

By  

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-06 ,pp. : 534-541

Karger

Access to resources Recommend Favorite

Unsuccessful Dasatinib Therapy in a Refractory Patient with Chronic Lymphocytic Leukemia

By  

Acta Haematologica, Vol. 124, Iss. 2, 2010-08 ,pp. : 103-104

Karger

Access to resources Recommend Favorite